NCT02478359

Brief Summary

Chronic obstructive pulmonary disease (COPD) is the third leading cause of the death in the US. The personal, social and economic costs of the disease are tremendous, with annual expenditures of nearly $50 billion, mostly from hospitalizations for exacerbations of COPD and associated sequelae. For the vast majority of patients, despite optimal pharmacological therapy, living with COPD is characterized by unrelieved dyspnea, physical inactivity, deconditioning, and an insidious downward spiral of social isolation and depression that has a profound impact on the lives of patients and their caregivers. There is mounting evidence that physical inactivity is significantly associated with more frequent hospitalizations and increased mortality in COPD even after adjusting for disease severity. While practice guidelines recommend regular physical activity for all patients with COPD, health systems are challenged in operationalizing an effective and sustainable approach to assist patients in being physically active. The investigators propose a pragmatic randomized controlled trial to determine the effectiveness of a 12-month physical activity coaching intervention (Walk On!) compared to standard care for 1,650 COPD patients from a large integrated health care system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,707

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

June 3, 2015

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 23, 2015

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

February 19, 2020

Completed
Last Updated

February 19, 2020

Status Verified

February 1, 2020

Enrollment Period

3.2 years

First QC Date

June 3, 2015

Results QC Date

March 5, 2019

Last Update Submit

February 7, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With All-cause Hospitalizations, Emergency Department (ED) Visits, Observation Stays, and Deaths

    Covariates included in the adjusted multivariate models were age, FEV1% predicted, Charlson comorbidity index, oxygen use, hospitalization for COPD in previous 12 months, outpatient treated COPD exacerbation in previous 12 months, length of time since acute care utilization to randomization, use of LABA or ICS, PA level and study site

    12 months following randomization

Secondary Outcomes (20)

  • Number of Deaths Among Participants

    12 months following randomization

  • Number of Participants With All-cause Hospitalizations

    12 months following randomization

  • Number of Participants With All-cause Emergency Department Visits

    12 months following randomization

  • Number of Participants With All-cause Observation Stays

    12 months following randomization

  • Number of Participants With COPD-Related Hospitalizations, ED Visits, and Observation Stays

    12 months following randomization

  • +15 more secondary outcomes

Other Outcomes (13)

  • Number of Participants With All-cause Hospitalization, Emergency Department (ED) Visits, Observation Stays and Deaths

    2 to 12 months following randomization

  • Number of Deaths Among Participants

    2 to 12 months following randomization

  • Number of Participants With All-cause Hospitalizations

    2 to 12 months following randomization

  • +10 more other outcomes

Study Arms (2)

Standard Care

NO INTERVENTION

Standard care patients received their routine care from Kaiser Permanente Southern California and had access to all health services in accordance with their health plan

Physical Activity Coaching (Walk On!)

EXPERIMENTAL

The 12-month Walk On! intervention included a baseline in-person assessment, collaborative monitoring of steps using two types of activity sensors, semi-automated step goal recommendations using an interactive voice response system or web application, ongoing individualized reinforcement from a physical activity coach, and peer/family support.

Behavioral: Physical Activity Coaching (Walk On!)

Interventions

The 12-month Walk On! intervention included a baseline in-person assessment, collaborative monitoring of steps using two types of activity sensors, semi-automated step goal recommendations using an interactive voice response system or web application, ongoing individualized reinforcement from a physical activity coach, and peer/family support.

Physical Activity Coaching (Walk On!)

Eligibility Criteria

Age41 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with any COPD-related hospitalization, emergency department visit or observational stay in the previous 12 months are eligible for the study. COPD-related encounters are defined according to the Centers for Medicare and Medicaid Services (CMS) and National Quality Forum (NQF) criteria for the Hospital Readmission Reduction Program. The following principal discharge diagnoses of COPD (ICD-9 codes: 491.21, 491.22, 491.8, 491.9, 492.8, 493.20, 493.21, 493.22, and 496) or respiratory failure (ICD-9 codes: 518.81, 518.82, 518.84, 799.1) with a secondary diagnosis of COPD exacerbation (ICD-9 codes: 491.21, 491.22, 493.21, 493.22) will be used
  • Age \>40 years
  • On at least a bronchodilator or steroid inhaler prior to the encounter or if not on an inhaler, had a previous COPD diagnosis
  • Continuous health plan membership in the 12 months prior to the encounter

You may not qualify if:

  • FEV1/FVC ratio \>0.70 at any point in the past year for those with spirometry data
  • Discharged to hospice, a skilled nursing facility, long term-care or another acute care hospital during the index admission
  • Level of function at admission or discharge during the index admission is bed bound
  • Has Alzheimers disease, dementia or metastatic cancer
  • Morbidly obese (BMI \>40)
  • Completed pulmonary rehabilitation in the last 6 months
  • Deceased
  • Dis-enrolled from the health plan

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaiser Permanente Southern California

Pasadena, California, 91101, United States

Location

Related Publications (3)

  • Nguyen HQ, Bailey A, Coleman KJ, Desai S, Fan VS, Gould MK, Maddock L, Miller K, Towner W, Xiang AH, Moy ML. Patient-centered physical activity coaching in COPD (Walk On!): A study protocol for a pragmatic randomized controlled trial. Contemp Clin Trials. 2016 Jan;46:18-29. doi: 10.1016/j.cct.2015.10.010. Epub 2015 Oct 24.

    PMID: 26597414BACKGROUND
  • Nguyen HQ, Moy ML, Fan VS, Gould MK, Xiang A, Bailey A, Desai S, Coleman KJ. Applying the pragmatic-explanatory continuum indicator summary to the implementation of a physical activity coaching trial in chronic obstructive pulmonary disease. Nurs Outlook. 2018 Sep;66(5):455-463. doi: 10.1016/j.outlook.2018.05.005. Epub 2018 Jul 12.

    PMID: 30144938BACKGROUND
  • Nguyen HQ, Moy ML, Liu IA, Fan VS, Gould MK, Desai SA, Towner WJ, Yuen G, Lee JS, Park SJ, Xiang AH. Effect of Physical Activity Coaching on Acute Care and Survival Among Patients With Chronic Obstructive Pulmonary Disease: A Pragmatic Randomized Clinical Trial. JAMA Netw Open. 2019 Aug 2;2(8):e199657. doi: 10.1001/jamanetworkopen.2019.9657.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Limitations and Caveats

It is important to note the low uptake/participation in the Walk On! intervention and its effects on the primary, intention to treat analyses, as well, the sub-optimal baseline and follow-up response rates to the patient-reported outcomes.

Results Point of Contact

Title
Huong Q2 Nguyen, Research Scientist
Organization
Kaiser Permanente

Study Officials

  • Huong Q Nguyen, PhD, RN

    Research Scientist

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist

Study Record Dates

First Submitted

June 3, 2015

First Posted

June 23, 2015

Study Start

June 1, 2015

Primary Completion

August 1, 2018

Study Completion

December 1, 2018

Last Updated

February 19, 2020

Results First Posted

February 19, 2020

Record last verified: 2020-02

Locations